APA (7th ed.) Citation

Kang-shuai Li, Yi Liu, Tie-zhong Zhang, Yun-fei Xu, & Zong-li Zhang. (2024). Protocol of REACH-01: A single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Kang-shuai Li, Yi Liu, Tie-zhong Zhang, Yun-fei Xu, and Zong-li Zhang. Protocol of REACH-01: A Single-arm, Open Label, Prospective Study of HAIC Sequential TAE Combined with Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Kang-shuai Li, et al. Protocol of REACH-01: A Single-arm, Open Label, Prospective Study of HAIC Sequential TAE Combined with Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma. Frontiers Media S.A., 2024.